Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences

BACKGROUND: Indacaterol is a novel, once-daily, inhaled, long-acting b2-agonist for patients with chronic obstructive pulmonary disease (COPD). The study objective was to evaluate the efficacy of indacaterol on quality of life and pulmonary function in patients with COPD in a real-world setting, and...

Full description

Saved in:
Bibliographic Details
Main Authors: Ohno, Takeshi, Wada, Shota, Hanada, Souichirou, Sawaguchi, Hirochiyo, Muraki, Masato, Tohda, Yuji
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2014
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3904808/
https://ncbi.nlm.nih.gov/pubmed/24489464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S56777
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items